Ukunyanga i-Alzheimer kunye ne-Dementia nge-Psychedelics

Ekuvaleni i-MYND ikhuphe i-450,000 yezabelo eziqhelekileyo (“Izabelo”) kwiCava ngexabiso eliqikelelwa ukuba yi-0.85 yeedola ngesabelo ngasinye kwaye yenza intlawulo eyimali eyi-120,000 yeedola njengengqwalasela yee-Asethi eziFundiweyo. Ukongeza, i-MYND iya kuhlawula kwi-Cava i-royalty yonyaka elingana nenkulu: (i) $ 240,000; okanye (ii) i-4% yentsalela yentengiso yayo nayiphi na imveliso okanye inkonzo ebandakanya ngokuthe ngqo okanye ngokungangqalanga ii-Asethi eziFunyiweyo kulo naliphi na iqela lesithathu.

Izabelo ziya kuxhomekeka kwixesha elisemthethweni lokubamba eliya kuphelelwa ngomhla oziinyanga ezine (4) kunye nosuku olunye ukususela kumhla wokuvala.

I-dementia yimeko etshabalalisayo ye-neurodeergenerative ekhokelela ekuboleni okuqatha kwabantu abadala kwaye iba mandundu ngokuya ngeminyaka. IWorld Health Organization iqikelela ukuba phakathi kwe-44 ne-50 yezigidi zabantu ehlabathini lonke banesifo sengqondo esiyingozi. Iindleko eziqikelelwayo zokunyamekela abantu abane-dementia, kuquka i-Alzheimer's Disease, e-USA kuphela, yayiyi-305 yeebhiliyoni zeedola ngo-2020 (umthombo: i-Alzheimer's Association) kwaye kulindeleke ukuba ifike kwi-1.1 yezigidigidi zeedola ngo-2050. Inani labantu baseMelika abaphila nesifo se-Alzheimer's kuqikelelwa ukuba iphantse yaphinda kathathu ngo-2050 ngaphandle kokuba kwenziwe uphuculo kukhathalelo lwezonyango. I-MYND ijonge ukuba phambili kule nkqubela phambili.

UGqr. Lyle Oberg, MD, i-CEO ye-MYND uthi: "I-Dementia, kuquka nesifo sika-Alzheimer, ichaphazela phantse zonke iintsapho ngandlela-thile, ngokuqhelekileyo kunye nemiphumo ebuhlungu kakhulu kunye neemvakalelo ezibuhlungu. “Njengoko siqhubeka nokutsalela umdla wabatyali-mali, siyakwazi ukuthatha amanyathelo abambekayo ukuya ngaphaya konyango lwangaphambili kunye nomsebenzi wezonyango kunye neqela lethu lophando. 

Ukufunyanwa luphawu olubalulekileyo lwe-MYND kwaye yakhela phezu kwamava abalulekileyo e-MYND kwicandelo lonyango lwengqondo encediswa yi-psilocybin, kubandakanywa neendlela zokudakumba okunganyangekiyo kunyango, phantsi kobunkokeli bukaGqr. Lyle Oberg, MD, i-CEO ye-MYND.

UMnu Theo Warkentin, i-CEO ye-Cava, wathi, "I-MYND yinkokeli yeshishini elitsha kwi-psychotherapy yengqondo, unyango kunye nokuxilongwa. Inkampani ikwindawo ekhethekileyo yokulandela ukusebenza kwe-psilocybin kunye nezinye ii-psychedelics ukunyanga isifo sengqondo esixhalabisayo.